Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

NYHA Class III Heart Failure clinical trials

1 of 2 indexed NYHA Class III Heart Failure trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

NYHA Class III Heart Failure: 2 US clinical trials tracked, 1 recruiting.

NYHA Class III Heart Failure is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is CardioMEMS, running 1 of these trials.

Enrollment posture brief

Registry condition nyha-class-iii-heart-failure

OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%NYHA Class III Heart Fai (th…50%
Open-enrollment share among volume-matched conditions near NYHA Class III Heart Failure

NYHA Class III Heart Failure lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for NYHA Class III Heart Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. NYHA Class III Heart Failure is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

CardioMEMS 1 trials
Impulse Dynamics 1 trials

Named interventions

Most-linked intervention names on NYHA Class III Heart Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CardioMEMS HF Pressure Measurement System Device
1 trials
Cardiac Contractility Modulation (CCM) Device
1 trials

US sites by state

Facility locations filed on NYHA Class III Heart Failure trials. A trial with sites in several states counts in each.

Tennessee 1 trials
Oklahoma 1 trials
Ohio 1 trials
New Jersey 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this NYHA Class III Heart Failure page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 NYHA Class III Heart Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • CardioMEMS sponsors the most NYHA Class III Heart Failure trials on record, review their full trial history before evaluating a specific study. See CardioMEMS's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This NYHA Class III Heart Failure condition card totals 2 registered trials; most-linked intervention CardioMEMS HF Pressure Measurement System; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.